149 related articles for article (PubMed ID: 1268386)
21. [Between Cortisone anxiety and euphoria. Pharmaceutical surveillance of long-term medication].
Bertsche T; Schulz M
Pharm Unserer Zeit; 2003; 32(4):323-9. PubMed ID: 12899070
[No Abstract] [Full Text] [Related]
22. Ophthalmic use of topical corticosteroids.
Angra SK
Indian J Ophthalmol; 1982 Jul; 30(4):213-8. PubMed ID: 7166392
[No Abstract] [Full Text] [Related]
23. [Cortisone therapy in chronic obstructive lung disease].
Vogelmeier C; Gillissen A
Dtsch Med Wochenschr; 2000 Feb; 125(8):220-3. PubMed ID: 10723458
[No Abstract] [Full Text] [Related]
24. [Use of prenacide magnetophoresis in complex treatment of some ocular diseases].
Alekseev BN; Tikhomirova TV
Vestn Oftalmol; 2003; 119(5):47-8. PubMed ID: 14598498
[No Abstract] [Full Text] [Related]
25. [Experimental and clinical study of the effectiveness of prednisolone eye drops].
Maĭchuk IuF
Vestn Oftalmol; 1970; 4():72-5. PubMed ID: 5502579
[No Abstract] [Full Text] [Related]
26. [Treatment of corneal injuries and eye disease with actihaemyl].
Grosse-Ruyken FJ
Klin Monbl Augenheilkd; 1982 Jun; 180(6):573-4. PubMed ID: 7132186
[TBL] [Abstract][Full Text] [Related]
27. [Adverse effects of local corticosteroid therapy].
Jorgensen PI
Ugeskr Laeger; 1972 Sep; 134(36):1906. PubMed ID: 5075000
[No Abstract] [Full Text] [Related]
28. Ophthalmic preparations.
Phillips M
Nurs Mirror; 1982 Dec 22-29; 155(24 Spec No):69-71. PubMed ID: 6925825
[No Abstract] [Full Text] [Related]
29. [Side effects of opthalmic drugs].
Shoji Y
Ganka; 1966 Nov; 8(11):944-5. PubMed ID: 6009789
[No Abstract] [Full Text] [Related]
30. [Prolonged corticotherapy for psoriasis in a young child. Arrest of statural growth. Erythroderma].
Rimbaud J; Meynadier J; Ravoire G
Bull Soc Fr Dermatol Syphiligr; 1969; 76(3):467-9. PubMed ID: 4252887
[No Abstract] [Full Text] [Related]
31. Advances in the treatment of allergic disorders of the eye.
Rohatgi JN; Singh HK; Siddiqui AA
Indian J Ophthalmol; 1982 Jul; 30(4):219-22. PubMed ID: 6820004
[No Abstract] [Full Text] [Related]
32. Advances in ocular corticosteroid therapy.
Levine SB; Leopold IH
Med Clin North Am; 1973 Sep; 57(5):1167-77. PubMed ID: 4601487
[No Abstract] [Full Text] [Related]
33. [Complications after intra-articular cortisone injections and medical liability].
Perret W
Hefte Unfallheilkd; 1969; 99():145-8. PubMed ID: 5397433
[No Abstract] [Full Text] [Related]
34. [Therapy of external eye diseases using Tanderil eye ointment].
Nemetz U
Klin Monbl Augenheilkd; 1972 May; 160(5):618-23. PubMed ID: 4627661
[No Abstract] [Full Text] [Related]
35. [Clinical and experimental studies on non-steroid anti-inflammatory agents].
Tokuda H; Kamano H; Fukuzawa H; Minatoya K
Nihon Ganka Kiyo; 1968 Oct; 19(10):993-8. PubMed ID: 4885034
[No Abstract] [Full Text] [Related]
36. Ocular inflammatory disease: use of topical and systemic anti-inflammatory agents.
Tessler HH
Manag Care; 2002 Jan; 11(1 Suppl):12-5; discussion 24-7. PubMed ID: 11842586
[No Abstract] [Full Text] [Related]
37. [Ophthalmological applications of hydrocortisone ointment].
Polos'iants OB
Klin Med (Mosk); 1999; 77(11):40-1. PubMed ID: 10635632
[TBL] [Abstract][Full Text] [Related]
38. [Inflmmation of sclera].
Fechner PU
Buch Augenarzt; 1976; 67(0):260. PubMed ID: 985722
[No Abstract] [Full Text] [Related]
39. [Osteoporosis and digestive disease].
Felly C; Frei A; Lamy O
Rev Med Suisse; 2006 Jan; 2(49):205-9. PubMed ID: 16493963
[TBL] [Abstract][Full Text] [Related]
40. [Dynamics of the enzymatic activity in the eye tissues and in the blood as an index of treatment effectiveness in uveitis].
Kovalevskiĭ EI; Faustov VS
Vestn Oftalmol; 1979; (2):48-51. PubMed ID: 433075
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
